Filter
544
Text search:
variants
Featured
80
52
Language
Document type
131
131
115
56
37
30
14
9
7
7
4
3
Countries
29
24
18
15
14
11
10
10
8
6
6
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
143
41
30
13
13
9
5
1
Toolboxes
261
34
21
17
17
16
15
15
11
9
7
7
7
5
4
4
4
3
2
2
2
1
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
Guidelines for Management and Treatment of Dyslipidemia in Indonesia
Towards the Peoples Health Assembly Book -4
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Lignes directrices.
Collection Avis et Rapports.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Copenhagen, Denmark, 24–25 August 2017
Updated to Reflect the 2009 Medical Eligibility Criteria of the World Health Organization
DHS Working Papers No. 98.
